Search

Your search keyword '"Van Broeckhoven C"' showing total 1,662 results

Search Constraints

Start Over You searched for: Author "Van Broeckhoven C" Remove constraint Author: "Van Broeckhoven C"
1,662 results on '"Van Broeckhoven C"'

Search Results

1. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

2. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

3. A novel Alzheimer disease locus located near the gene encoding tau protein

4. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimerʼs and Parkinsonʼs diseases

9. Using global team science to identify genetic parkinson's disease worldwide

10. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

11. Extensive genetic and phenotypic description of MAPT p.R406W in the Flanders-Belgian population

13. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels

14. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

15. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

16. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

17. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

18. APOE and Alzheimer disease: a major gene with semi-dominant inheritance

25. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

26. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

27. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

29. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

30. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

35. Octapeptide repeat insertions in the prion protein gene and early onset dementia

36. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

37. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimerʼs disease

40. Molecular Diagnosis of Neurogenetic Disorders: Motoneuron, Peripheral Nerve and Muscle Disorders

41. Molecular Diagnosis of Mitochondrial Disorders

42. Molecular Diagnosis of Channelopathies, Epilepsies, Migraine, Stroke and Dementias

43. Molecular Diagnosis of Neurogenetic Disorders: General Issues, Huntington's Disease, Parkinson's Disease and Dystonias

44. Molecular Diagnosis of Ataxias and Spastic Paraplegias

46. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects

Catalog

Books, media, physical & digital resources